Haemonetics Reports Q1 FY26 Earnings; Conference Call Scheduled for Aug. 7.
PorAinvest
jueves, 7 de agosto de 2025, 6:20 am ET1 min de lectura
HAE--
The results show a decrease in revenue of $321 million, a 4% organic revenue increase, and a 12.9% organic ex-CSL revenue increase. Earnings per diluted share stood at $0.70, with adjusted earnings per diluted share at $1.10. Cash flow from operating activities was $17 million, and free cash flow was $2 million. Gross margin was 59.8% in the first quarter of fiscal 2026 compared to 52.0% in the first quarter of fiscal 2025.
Operating expenses increased by $3.2 million or 2.4% compared to the first quarter of fiscal 2025, driven by increased investments in research and development. The income tax rate was 25% in the first quarter of fiscal 2026, compared to 18% in the first quarter of fiscal 2025.
Haemonetics reaffirmed its previous fiscal 2026 GAAP total revenue and organic revenue growth guidance. The company also reaffirmed its adjusted operating margin guidance, adjusted earnings per diluted share guidance, and free cash flow guidance.
The webcast and conference call will provide further insights into the company's performance and future plans. Investors and analysts are encouraged to participate and access the replay for detailed analysis.
References:
[1] https://www.stocktitan.net/news/HAE/haemonetics-1st-quarter-fiscal-year-2026-earnings-release-32i3x2nuiovt.html
[2] https://www.marketscreener.com/news/haemonetics-q1-2026-haemonetics-corporation-earnings-release-ce7c5edfdb88f321
• Haemonetics releases Q1 FY26 financial results online. • Conference call and webcast set for August 7, 2025. • Results available on Investor Relations website. • Live webcast accessible via Haemonetics' investor relations website.
Haemonetics Corporation (NYSE: HAE) has announced the availability of its first quarter fiscal year 2026 financial results on its Investor Relations website. The company will host a conference call and webcast with investors and analysts on August 7, 2025, at 8:00 a.m. ET to discuss the results. The conference call requires pre-registration, and participants are recommended to join 10 minutes before the event. A replay of the conference call and webcast will be accessible for one year starting from August 7, 2025, at 11:00 a.m. ET.The results show a decrease in revenue of $321 million, a 4% organic revenue increase, and a 12.9% organic ex-CSL revenue increase. Earnings per diluted share stood at $0.70, with adjusted earnings per diluted share at $1.10. Cash flow from operating activities was $17 million, and free cash flow was $2 million. Gross margin was 59.8% in the first quarter of fiscal 2026 compared to 52.0% in the first quarter of fiscal 2025.
Operating expenses increased by $3.2 million or 2.4% compared to the first quarter of fiscal 2025, driven by increased investments in research and development. The income tax rate was 25% in the first quarter of fiscal 2026, compared to 18% in the first quarter of fiscal 2025.
Haemonetics reaffirmed its previous fiscal 2026 GAAP total revenue and organic revenue growth guidance. The company also reaffirmed its adjusted operating margin guidance, adjusted earnings per diluted share guidance, and free cash flow guidance.
The webcast and conference call will provide further insights into the company's performance and future plans. Investors and analysts are encouraged to participate and access the replay for detailed analysis.
References:
[1] https://www.stocktitan.net/news/HAE/haemonetics-1st-quarter-fiscal-year-2026-earnings-release-32i3x2nuiovt.html
[2] https://www.marketscreener.com/news/haemonetics-q1-2026-haemonetics-corporation-earnings-release-ce7c5edfdb88f321
Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios